Skip to main content

10x Genomics

10x Genomics Inc is an American multinational life sciences technology enterprise specializing in the design, development, and commercialization of advanced instruments, consumables, and software for single-cell and spatial biology research. The company produces innovative genomic analysis platforms (such as Chromium and Visium) that enable researchers to interrogate biological systems at single-cell and subcellular resolution, driving breakthroughs in oncology, immunology, and neuroscience. Its core business operations encompass life sciences instrument engineering, microfluidic consumable manufacturing, bioinformatics software development, and global wholesale distribution. Revenue is derived primarily from instrument sales, consumable reagent kits, and recurring software licensing fees. 10x Genomics holds a dominant global market position in single-cell sequencing hardware and spatial biology solutions. The company is headquartered in Pleasanton, California, United States, and its Class A common stock trades on the Nasdaq Global Select Market under the ticker TXG.

7 of the funds FundTelligence covers report a position in 10x Genomics.

Legal name
10x Genomics Inc
Sector
Health Care
Country
United States
Funds holding it
7
Exposure themes
Genomics & Profiling, Precision Medicine & Genomics, Single-Cell & Multiomics

Funds holding 10x Genomics

Loading...